MyFinsight
Home
About
Contact
erna: the income statement
Download
Download image
Net loss
attributable to common...
-$1,240K
(95.34%↑ Y/Y)
Net loss
-$1,240K
(95.34%↑ Y/Y)
Interest income
(expense), net
$31K
(101.84%↑ Y/Y)
Gain (loss) on
extinguishment of debt
$734K
(103.27%↑ Y/Y)
Provision for income taxes
$6K
(-50.00%↓ Y/Y)
Loss before income
taxes
-$1,234K
(95.36%↑ Y/Y)
Total other income
(expense), net
$759K
(103.12%↑ Y/Y)
Other expense, net
-$6K
Loss from operations
-$1,993K
(11.78%↑ Y/Y)
Total operating
expenses
$1,993K
(-28.97%↓ Y/Y)
General and
administrative
$958K
(-71.67%↓ Y/Y)
Research and development
$1,035K
(3.40%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Ernexa Therapeutics Inc. (ERNA)
Ernexa Therapeutics Inc. (ERNA)